Filing Details

Accession Number:
0000791908-15-000050
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-23 18:35:45
Reporting Period:
2015-03-23
Filing Date:
2015-03-23
Accepted Time:
2015-03-23 18:35:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
791908 Xoma Corp XOMA Pharmaceutical Preparations (2834) 942756657
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1210905 D Paul Rubin C/O Xoma Corporation
2910 Seventh Street
Berkeley CA 94710
Sr. Vp Clinical Dev. & Cmo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2015-03-23 32,742 $3.94 119,467 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares 6,881 Indirect by 401(k)
Footnotes
  1. This transaction was made pursuant to Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2014.
  2. This transaction was executed in multiple trades ranging at prices from $3.780 to $4.020.The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Company or a security holder of the Company full information regarding the number of shares and prices at which the transactions were effected.